
More nausea reported.
Higher rate of GI side effects in head-to-head trials, especially during dose escalation.
| Tier | BMI | Primary benefit | Also provides |
|---|---|---|---|
| Microdose | 19–22 | Longevity & metabolic optimization | Anti-inflammatory, cardiovascular |
| Low Dose | 22–28 | Gentle weight loss | Anti-inflammatory, cardiovascular |
| Normal Dose | 28+ | Full weight loss | All underlying metabolic benefits |
Final tier is confirmed by your clinician based on your full medical intake.
We're currently licensed in Texas, California, Florida, New York.
Choose all that apply. These are standard safety screens for GLP-1 therapy.
Pick None of these if you're clear, or check any that apply.
We use this to calculate your BMI, which determines your tier eligibility.
If your weight fluctuates, use your highest recent weight.
Select all that apply. Some of these unlock the full Normal-dose tier even if your BMI is below 30.
If you've ever been told by a doctor that you have any of these, check the box. Don't worry if you're not sure - your clinician will confirm everything.
GLP-1s can cause nausea or GI upset, especially during the first few weeks. The two compounds are not the same on this front.

More nausea reported.
Higher rate of GI side effects in head-to-head trials, especially during dose escalation.

Less nausea on average.
Better-tolerated GI profile in head-to-head data, even at matched intensities.
Based on SURMOUNT-5, the head-to-head trial comparing tirzepatide and semaglutide.
Reaching your target dose faster means weight loss starts sooner. Slower means a smoother ride. This is titration time, not weight-loss time.

~15% body weight lost.
Average at 68 weeks at full dose. STEP trials.

~21% body weight lost.
Average at 72 weeks at full dose. SURMOUNT trials.
These percentages are at full dose only.
This helps your clinician set your target dose within your tier.


GLP therapy can lower weight — but it doesn't distinguish between fat and muscle. A GH peptide may help preserve lean tissue while you lose fat.


Your clinician confirms the right peptide and dose at your appointment.

GH peptides are safe for most adults. Two conditions need clinician review. Most patients leave both unchecked.
Craft Peptides is currently licensed in Texas, California, Florida, New York. We're expanding to additional states. Join the waitlist and we'll let you know when we're available where you live.
Based on what you shared, GLP-1 therapy may not be a safe match through our standard intake. A licensed clinician will review your full history before any treatment decision is made. You can book a consultation to discuss alternative options.
Our lowest tier (Microdose) requires a BMI of 19 or above. If your weight fluctuates, use your highest recent weight, or book a consultation to discuss alternatives.